Pizzato Margherita, Santucci Claudia, Islam Nazrul, La Vecchia Carlo, Alicandro Gianfranco
Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Int J Epidemiol. 2024 Dec 16;54(1). doi: 10.1093/ije/dyaf006.
During the COVID-19 pandemic, mortality from some chronic diseases increased. In this study, we evaluated monthly excess mortality from all causes, cancer, cardiovascular diseases (CVD) and diabetes during the months of 2020 and 2021, examining its relationship with COVID-19 cases.
Monthly cause-specific mortality data were downloaded from public repositories of national statistics offices or directly requested from them, and population data were obtained from the United Nations archives. Excess deaths were estimated as the difference between observed and expected deaths. Monthly expected deaths for 2020 and 2021 were calculated using a quasi-Poisson regression model trained on 2010-19 data (or a shorter timespan if the full decade of data was not available). To quantify the correlation between COVID-19 cases and monthly excess mortality, we used the Spearman's correlation coefficient (rs).
The study included 16 countries that provided monthly national data on causes of death (Argentina, Austria, Brazil, Switzerland, Chile, the Czech Republic, Germany, Georgia, Hungary, Italy, Lithuania, Latvia, Mexico, Serbia, Slovakia and the USA). A positive correlation was found between COVID-19 cases and monthly excess mortality from all causes in all countries (rs ranging from 0.61 to 0.91), from CVD in 11 countries (rs ranging from 0.45 to 0.85) and for diabetes in 13 countries (rs ranging from 0.42 to 0.79). Excess mortality above 5% was estimated from all causes in 14 countries for both 2020 and 2021, from CVD in seven countries for 2020 and in nine countries for 2021, and from diabetes in 11 countries for 2020 and in 12 countries for 2021. No excess above 5% was estimated for cancer mortality in any of the countries considered.
Excess mortality from CVD and diabetes persisted in several countries throughout 2021. These increases coincide with COVID-19 peaks, supporting a short-term impact of the COVID-19 pandemic on mortality from these causes.
在新冠疫情期间,一些慢性病的死亡率有所上升。在本研究中,我们评估了2020年和2021年各月所有原因、癌症、心血管疾病(CVD)和糖尿病导致的超额死亡率,并研究了其与新冠病例的关系。
从各国统计局的公共数据库下载每月特定病因死亡率数据,或直接向其索取,人口数据则从联合国档案中获取。超额死亡人数估计为观察到的死亡人数与预期死亡人数之差。2020年和2021年的每月预期死亡人数使用基于2010 - 2019年数据训练的准泊松回归模型计算(如果没有完整十年的数据,则使用较短的时间跨度)。为了量化新冠病例与每月超额死亡率之间的相关性,我们使用了斯皮尔曼相关系数(rs)。
该研究纳入了16个提供每月全国死因数据的国家(阿根廷、奥地利、巴西、瑞士、智利、捷克共和国、德国、格鲁吉亚、匈牙利、意大利、立陶宛、拉脱维亚、墨西哥、塞尔维亚、斯洛伐克和美国)。在所有国家,新冠病例与所有原因导致的每月超额死亡率之间均呈正相关(rs范围为0.61至0.91),在11个国家中与心血管疾病导致的超额死亡率呈正相关(rs范围为0.45至0.85),在13个国家中与糖尿病导致的超额死亡率呈正相关(rs范围为0.42至0.79)。2020年和2021年,14个国家所有原因导致的超额死亡率估计超过5%,2020年7个国家心血管疾病导致的超额死亡率超过5%,2021年9个国家超过5%,2020年11个国家糖尿病导致的超额死亡率超过5%,2021年12个国家超过5%。在所考虑的任何国家中,癌症死亡率均未估计出超过5%的超额死亡率。
2021年全年,心血管疾病和糖尿病导致的超额死亡率在多个国家持续存在。这些增加与新冠疫情高峰相吻合,支持了新冠疫情对这些原因导致的死亡率产生短期影响的观点。